{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:22:23Z","timestamp":1787311343890,"version":"build-2736575974"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Protocols"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Skin is made up of an epidermis and, dermis which serve as a barrier against physical and environmental threats. Keratinocytes make up greater than 95% of the epidermis and form different layers based on their level of differentiation. Millions of individuals suffer from skin diseases, which are characterized by significant barrier disruption and inflammation. Investigators previously relied on animal models to investigate inflammatory skin diseases; however, technological advances have enabled the use of physiologically human skin models to investigate the effects of inflammatory mediators on the structure and function of skin cells. In this article, we describe two protocols using keratinocytes to investigate tumor necrosis factor alpha (TNF\u2010\u03b1) and interferon gamma (IFN\u2010\u03b3) driven skin inflammation as a surrogate for psoriasis, vitiligo, and other autoimmune skin diseases driven by these cytokines. \u00a9 2021 Wiley Periodicals LLC.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Basic Protocol 1<\/jats:bold>\n                    : Preparing a HaCaT keratinocyte culture\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Basic Protocol 2<\/jats:bold>\n                    : 3\u2010Dimensional organotypic skin cultures to assess TNF\u2010\u03b1 and IFN\u2010\u03b3\u00a0driven skin inflammation\n                  <\/jats:p>","DOI":"10.1002\/cpz1.72","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T16:13:45Z","timestamp":1615220025000},"source":"Crossref","is-referenced-by-count":12,"title":["Modeling Skin Inflammation Using Human In Vitro Models"],"prefix":"10.1002","volume":"1","author":[{"given":"Erika","family":"Boarder","sequence":"first","affiliation":[{"name":"Incyte Research Institute  Wilmington Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Rumberger","sequence":"additional","affiliation":[{"name":"Incyte Research Institute  Wilmington Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Howell","sequence":"additional","affiliation":[{"name":"DermTech  La Jolla California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.984"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.048"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1586\/eem.12.34"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016\u2010017\u20108622\u20107"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2019.1707455"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091089"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15339"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7435621"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100625.2006.00437.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523\u20101747.2001.01327.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396\u20100296.2004.04S1001.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.04.031"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.08.087"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3030268"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5538"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.24"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.04.006"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/JDN.0b013e3182274a98"},{"key":"e_1_2_7_20_1","first-page":"443","article-title":"Topical administration of reversible SAHH inhibitor ameliorates imiquimod\u2010induced psoriasis\u2010like skin lesions in mice via suppression of TNF\u2010\u03b1\/IFN\u2010\u03b3\u2010induced inflammatory response in keratinocytes and T cell\u2010derived IL\u201017","volume":"129","author":"Lin Z. M.","year":"2018","journal-title":"Pharmacology Reports"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346\u20108138.2011.01483.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.6.3262"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02521744"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100625.2008.00786.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016\u2010017\u20108627\u20102"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153289"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13671\u2010017\u20100192\u20107"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100625.1993.tb00030.x"},{"issue":"2","key":"e_1_2_7_30_1","first-page":"189","article-title":"Role of the calcium\u2010sensing receptor in calcium regulation of epidermal differentiation and function","volume":"30","author":"Tu C. L.","year":"2013","journal-title":"Best Practic & Research Clinical Endocrinology & Metabolism"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.249"},{"key":"e_1_2_7_32_1","volume-title":"Skin Care in Wound Management: Assessment, Prevention and Treatment","author":"White R.","year":"2005"}],"container-title":["Current Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpz1.72","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpz1.72","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpz1.72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T07:57:42Z","timestamp":1692604662000},"score":1,"resource":{"primary":{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/10.1002\/cpz1.72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1002\/cpz1.72"],"URL":"https:\/\/doi.org\/10.1002\/cpz1.72","archive":["Portico"],"relation":{},"ISSN":["2691-1299","2691-1299"],"issn-type":[{"value":"2691-1299","type":"print"},{"value":"2691-1299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"article-number":"e72"}}